Poor health status and distress in cardiac patients: The role of device therapy vs. underlying heart disease

Europace

Volumn 15, Issue 3, 2013, Pages 355-361

  Habibović, Mirela ^a   Versteeg, Henneke ^a   Pelle, Aline J M ^a   Theuns, Dominic A M J ^b   Jordaens, Luc ^b   Pedersen, Susanne S ^a,b  

^a TILBURG UNIVERSITY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Anxiety; Congestive heart failure; Depression; Health status; Implantable cardioverter defibrillator

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; DEPRESSION; DISTRESS SYNDROME; EFFECT SIZE; FEMALE; HEALTH STATUS; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; ANXIETY; CHI-SQUARE DISTRIBUTION; COST OF ILLNESS; DEFIBRILLATORS, IMPLANTABLE; DEPRESSION; ELECTRIC COUNTERSHOCK; EQUIPMENT DESIGN; EQUIPMENT FAILURE; FEMALE; HEALTH STATUS; HEART FAILURE; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; MULTIVARIATE ANALYSIS; NETHERLANDS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 84874405248     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus295     Document Type: Article

References (31)

1. Brignole M. Are complications of implantable defibrillators under-estimated and benefits over-estimated? Europace 2009;11:1129-33.
2. Tung R, Zimetbaum P, Josephson ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol 2008;52:1111-21.
3. Sears SF, Lewis TS, Kuhl EA, Conti JB. Predictors of quality of life in patients with implantable cardioverter defibrillators. Psychosomatics 2005;46:451-7.
4. Passman R, Subacius H, Ruo B, Schaechter A, Howard A, Sears SF et al. Implantable cardioverter defibrillators and quality of life: Results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study. Arch Intern Med 2007; 167:2226-32.
5. Pedersen SS, Van den Broek KC, Van den Berg M, Theuns DA. Shocks as a determinant of poor patient-centered outcomes in implantaple cardioverter defibrillator patients: Is there more to it than meets the eye? Pacing Clin Electrophysiol 2009;33:1430-6.
6. Magyar-Russell G, Thombs BD, Cai JX, Baveja T, Kuhl EA, Singh PP et al. The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: A systematic review. J Psychosom Res 2011;71:223-31.
7. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 2006;48:1527-37.
8. Irvine J, Dorian P, Baker B, O'Brien BJ, Roberts R, Gent M et al. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J 2002;144:282-9.
9. Mark DB, Anstrom KJ, Sun JL, Clapp-Channing NE, Tsiatis AA, Davidson-Ray L et al. Quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med 2008;359:999-1008.
10. Redhead AP, Turkington D, Rao S, Tynan MM, Bourke JP. Psychopathology in postinfarction patients implanted with cardioverter-defibrillators for secondary prevention. A cross-sectional, case-controlled study. J Psychosom Res 2010;69: 555-63.
11. Leosdottir M, Sigurdsson E, Reimarsdottir G, Gottskalksson G, Torfason B, Vigfusdottir M et al. Health-related quality of life of patients with implantable cardioverter defibrillators compared with that of pacemaker recipients. Europace 2006;8:168-74.
12. Herbst JH, Goodman M, Feldstein S, Reilly JM. Health-related quality-of-life assessment of patients with life-threatening ventricular arrhythmias. Pacing Clin Electrophysiol 1999;22:915-26.
13. Epstein AE. Subject of the year: Who are we missing, who are we overtreating, and who is best served? Refining the prescription of implantable cardioverterdefibrillator therapy. J Interv Card Electrophysiol 2009;26:91-4.
14. Pedersen SS, van den Broek KC, Erdman RA, Jordaens L, Theuns DA. Pre implantation implantable cardioverter defibrillator concerns and Type D personality increase the risk of mortality in patients with an implantable carioverter defibrillator. Europace 2010;12:1446-52.
15. Pelle AJ, Pedersen SS, Szabo BM, Denollet J. Beyond Type D personality: Reduced positive affect (anhedonia) predicts impaired health status in chronic heart failure. Qual Life Res 2009;18:689-98.
16. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Medical Care 1996;34:220-33.
17. Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE et al. Crossvalidation of item selection and scoring for the SF-12 Health Survey in nine countries: Results from the IQOLA Project. International Quality of Life Assessment. Journal of Clinical Epidemiology 1998;51:1171-8.
18. Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: Summary of results from the Medical Outcomes Study. Med Care 1995;33:AS264-279.
19. Mols F, Pelle AJ, Kupper N. Normative data of the SF-12 health survey with validation using postmyocardial infarction patients in the Dutch population. Qual Life Res 2009;18:403-14.
20. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70.
21. Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 1997;27:363-70.
22. Martin CR, Lewin RJ, Thompson DR. A confirmatory factor analysis of the Hospital Anxiety and Depression Scale in coronary care patients following acute myocardial infarction. Psychiatry Res 2003;120:85-94.
23. Van Ginkel J, Van der Ark L. SPSS syntax for missing value imputation in test and questionnaire data. Appl Psych Meas 2005;29:152-3.
24. Pedersen SS, Versteeg H, Nielsen JC, Mortensen PT, Johansen JB. Patient reported outcomes in Danish implantable cardioverter defibrillator patients with a Sprint Fidelis lead advisory notification. Europace 2011;13:109-20.
25. Thomas SA, Friedmann E, Gottlieb SS, Liu F, Morton PG, Chapa DW et al. Changes in psychosocial distress in outpatients with heart failure with implantable cardioverter defibrillators. Heart Lung 2009;38:109-20.
26. Pedersen SS, Hoogwegt MT, Jordaens L, Theuns DA. Relation of symptomatic heart failure and psychological status to persistent depression in patients with implantable cardioverter-defibrillator. Am J Cardiol 2011;108:69-74.
27. Piotrowicz K, Noyes K, Lyness JM, McNitt S, Andrews ML, Dick A et al. Physical functioning and mental well-being in association with health outcome in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial II. Eur Heart J 2007;28:601-7.
28. WhangW, Albert CM, Sears SF Jr, Lampert R, Conti JB,Wang PJ et al. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: Results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol 2005;45:1090-5.
29. Pedersen SS, Denollet J, de Jonge P, Simsek C, Serruys PW, van Domburg RT. Brief depression screening with the PHQ-2 associated with prognosis following percutaneous coronary intervention with paclitaxel-eluting stenting. J Gen Intern Med 2009;24:1037-42.
30. Pedersen SS, van den Broek KC, Sears SF Jr. Psychological intervention following implantation of an implantable defibrillator: A review and future recommendations. Pacing Clin Electrophysiol 2007;30:1546-54.
31. Dunbar SB, Langberg JJ, Reilly CM, Viswanathan B, McCarty F, Culler SD et al. Effect of a psychoeducational intervention on depression, anxiety, and health resource use in implantable cardioverter defibrillator patients. Pacing Clin Electrophysiol 2009;32:1259-71.